Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc.（PLRX）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · PLRX · 截至 2025年9月30日
股东结构概览
104
机构持有人数
▼ 12 vs Q2
$74.65M
机构持仓总市值
▲ $14.93M vs Q2
61.92M
总流通股
freeFloat 97.27%
50.45M
13F 申报持股数
▼ 1.04M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
PLRX 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
TANG CAPITAL MANAGEMENT LLC pharmaceutical preparations | 6.00M | 9.78% | 9.78% | $8.89B | Nov 14, 2025 | ▲ 3.4K |
WOODLINE PARTNERS LP pharmaceutical preparations | 4.50M | 7.34% | 7.34% | $6.67B | Nov 14, 2025 | ▲ 2.16M |
POINT72 ASSET MANAGEMENT, L.P. pharmaceutical preparations | 4.34M | 7.07% | 7.07% | $6.42B | Nov 14, 2025 | NEW |
MORGAN STANLEY pharmaceutical preparations | 3.51M | 5.71% | 5.71% | $5.19B | May 27, 2026 | ▼ 246.3K |
BLUE OWL CAPITAL HOLDINGS LP pharmaceutical preparations | 2.97M | 4.84% | 4.84% | $4.39B | Nov 12, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 2.78M | 4.52% | 4.52% | $4.11B | Nov 7, 2025 | ▼ 226.4K |
ACADIAN ASSET MANAGEMENT LLC pharmaceutical preparations | 2.37M | 3.86% | 3.86% | $3.50B | Nov 13, 2025 | ▲ 739.1K |
CITADEL ADVISORS LLC pharmaceutical preparations | 2.34M | 3.81% | 3.81% | $3.46B | Nov 14, 2025 | ▼ 16.4K |
JPMORGAN CHASE & CO pharmaceutical preparations | 2.13M | 3.47% | 3.47% | $3.15B | Nov 26, 2025 | ▲ 172.1K |
REDMILE GROUP, LLC pharmaceutical preparations | 1.59M | 2.59% | 2.59% | $2.36B | Nov 14, 2025 | ▼ 40.9K |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
23
增持
+6.91M 股5
新建仓
首次建仓14
减持
−3.23M 股0
清仓
完全退出净股数变化（前50家）
+3.69M
+6.91M / −3.23M
净新增持仓人
+14
新建 5 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
PLRX 内幕交易记录
数据来源：SEC Form 4
20
买入笔数
20
卖出笔数
1.00
买卖比
$3M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Kuo Minnie Chief Operating Officer | Apr 17, 2026 | Award | 150,000 | $1.33 | $199.5K | 150.0K | Form 4 ↗ |
Kuo Minnie Chief Operating Officer | Apr 17, 2026 | Award | 55,200 | $1.33 | $73.4K | 55.2K | Form 4 ↗ |
Kuo Minnie Chief Operating Officer | Apr 17, 2026 | Award | 40,000 | $1.33 | $53.2K | 40.0K | Form 4 ↗ |
Kuo Minnie Chief Operating Officer | Apr 17, 2026 | D-Return | 150,000 | $16.18 | $2.43M | 0 | Form 4 ↗ |
Kuo Minnie Chief Operating Officer | Apr 17, 2026 | D-Return | 40,000 | $17.44 | $697.6K | 0 | Form 4 ↗ |
Kuo Minnie Chief Operating Officer | Apr 17, 2026 | D-Return | 55,200 | $11.14 | $614.9K | 0 | Form 4 ↗ |
Cummings Keith Lamont Chief Financial Officer | Apr 17, 2026 | Award | 124,000 | $1.33 | $164.9K | 124.0K | Form 4 ↗ |
Cummings Keith Lamont Chief Financial Officer | Apr 17, 2026 | Award | 113,300 | $1.33 | $150.7K | 113.3K | Form 4 ↗ |
Cummings Keith Lamont Chief Financial Officer | Apr 17, 2026 | Award | 110,500 | $1.33 | $147.0K | 110.5K | Form 4 ↗ |
Cummings Keith Lamont Chief Financial Officer | Apr 17, 2026 | Award | 76,200 | $1.33 | $101.3K | 76.2K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Pliant Therapeutics, Inc.（PLRX）主要由机构投资者持有，机构持股比例约为 81.5%。公司内部人员持股约 2.73%，散户及公众持股约占剩余的 15.80%。
Pliant Therapeutics, Inc. 最大机构股东为 TANG CAPITAL MANAGEMENT LLC，截至 September 30, 2025 持有约 6.00 million 股，占总流通股的 9.78%。
目前共有 104 家机构持有 PLRX 股票，合计持仓市值约 $74,654,754，数据来源为最新 SEC 13F 申报。
常见问题
PLRX ownershipPliant Therapeutics, Inc.（PLRX）主要由机构投资者持有，机构持股约 81.5%。最大股东为 TANG CAPITAL MANAGEMENT LLC，持股比例 9.78%。内部人员持股约 2.73%。数据来源 SEC Form 13F，截至 September 30, 2025。